-
1
-
-
73249125200
-
Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis
-
Bartok B., Firestein G.S. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev 2010, 233(1):233-255.
-
(2010)
Immunol Rev
, vol.233
, Issue.1
, pp. 233-255
-
-
Bartok, B.1
Firestein, G.S.2
-
2
-
-
0030903094
-
The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis
-
Okamoto H., Yamamura M., Morita Y., Harada S., Makino H., Ota Z. The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis. Arthritis Rheum 1997, 40(6):1096-1105.
-
(1997)
Arthritis Rheum
, vol.40
, Issue.6
, pp. 1096-1105
-
-
Okamoto, H.1
Yamamura, M.2
Morita, Y.3
Harada, S.4
Makino, H.5
Ota, Z.6
-
3
-
-
0031456588
-
Oncostatin M stimulates monocyte chemoattractant protein-1- and interleukin-1-induced matrix metalloproteinase-1 production by human synovial fibroblasts in vitro
-
Langdon C., Leith J., Smith F., Richards C.D. Oncostatin M stimulates monocyte chemoattractant protein-1- and interleukin-1-induced matrix metalloproteinase-1 production by human synovial fibroblasts in vitro. Arthritis Rheum 1997, 40(12):2139-2146.
-
(1997)
Arthritis Rheum
, vol.40
, Issue.12
, pp. 2139-2146
-
-
Langdon, C.1
Leith, J.2
Smith, F.3
Richards, C.D.4
-
4
-
-
0030906014
-
Detection of oncostatin M in synovial fluid from patients with rheumatoid arthritis
-
Hui W., Bell M., Carroll G. Detection of oncostatin M in synovial fluid from patients with rheumatoid arthritis. Ann Rheum Dis 1997, 56(3):184-187.
-
(1997)
Ann Rheum Dis
, vol.56
, Issue.3
, pp. 184-187
-
-
Hui, W.1
Bell, M.2
Carroll, G.3
-
5
-
-
18244411482
-
The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint
-
Cawston T.E., Curry V.A., Summers C.A., Clark I.M., Riley G.P., Life P.F., et al. The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint. Arthritis Rheum 1998, 41(10):1760-1771.
-
(1998)
Arthritis Rheum
, vol.41
, Issue.10
, pp. 1760-1771
-
-
Cawston, T.E.1
Curry, V.A.2
Summers, C.A.3
Clark, I.M.4
Riley, G.P.5
Life, P.F.6
-
6
-
-
0034040139
-
Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis
-
Manicourt D.H., Poilvache P., Van Egeren A., Devogelaer J.P., Lenz M.E., Thonar E.J. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis. Arthritis Rheum 2000, 43(2):281-288.
-
(2000)
Arthritis Rheum
, vol.43
, Issue.2
, pp. 281-288
-
-
Manicourt, D.H.1
Poilvache, P.2
Van Egeren, A.3
Devogelaer, J.P.4
Lenz, M.E.5
Thonar, E.J.6
-
7
-
-
0038312971
-
Growth plate damage, a feature of juvenile idiopathic arthritis, can be induced by adenoviral gene transfer of oncostatin M: a comparative study in gene-deficient mice
-
de Hooge A.S., van de Loo F.A., Bennink M.B., Arntz O.J., Fiselier T.J., Franssen M.J., et al. Growth plate damage, a feature of juvenile idiopathic arthritis, can be induced by adenoviral gene transfer of oncostatin M: a comparative study in gene-deficient mice. Arthritis Rheum 2003, 48(6):1750-1761.
-
(2003)
Arthritis Rheum
, vol.48
, Issue.6
, pp. 1750-1761
-
-
de Hooge, A.S.1
van de Loo, F.A.2
Bennink, M.B.3
Arntz, O.J.4
Fiselier, T.J.5
Franssen, M.J.6
-
8
-
-
0033558303
-
Oncostatin M production and regulation by human polymorphonuclear neutrophils
-
Grenier A., Dehoux M., Boutten A., Arce-Vicioso M., Durand G., Gougerot-Pocidalo M.A., et al. Oncostatin M production and regulation by human polymorphonuclear neutrophils. Blood 1999, 93(4):1413-1421.
-
(1999)
Blood
, vol.93
, Issue.4
, pp. 1413-1421
-
-
Grenier, A.1
Dehoux, M.2
Boutten, A.3
Arce-Vicioso, M.4
Durand, G.5
Gougerot-Pocidalo, M.A.6
-
9
-
-
67650074530
-
Induction of CCL13 expression in synovial fibroblasts highlights a significant role of oncostatin M in rheumatoid arthritis
-
Hintzen C., Quaiser S., Pap T., Heinrich P.C., Hermanns H.M. Induction of CCL13 expression in synovial fibroblasts highlights a significant role of oncostatin M in rheumatoid arthritis. Arthritis Rheum 2009, 60(7):1932-1943.
-
(2009)
Arthritis Rheum
, vol.60
, Issue.7
, pp. 1932-1943
-
-
Hintzen, C.1
Quaiser, S.2
Pap, T.3
Heinrich, P.C.4
Hermanns, H.M.5
-
10
-
-
0035149165
-
Amelioration of arthritis in two murine models using antibodies to oncostatin M
-
Plater-Zyberk C., Buckton J., Thompson S., Spaull J., Zanders E., Papworth J., et al. Amelioration of arthritis in two murine models using antibodies to oncostatin M. Arthritis Rheum 2001, 44(11):2697-2702.
-
(2001)
Arthritis Rheum
, vol.44
, Issue.11
, pp. 2697-2702
-
-
Plater-Zyberk, C.1
Buckton, J.2
Thompson, S.3
Spaull, J.4
Zanders, E.5
Papworth, J.6
-
11
-
-
0037906397
-
Adenoviral gene transfer of interleukin-1 in combination with oncostatin M induces significant joint damage in a murine model
-
Rowan A.D., Hui W., Cawston T.E., Richards C.D. Adenoviral gene transfer of interleukin-1 in combination with oncostatin M induces significant joint damage in a murine model. Am J Pathol 2003, 162(6):1975-1984.
-
(2003)
Am J Pathol
, vol.162
, Issue.6
, pp. 1975-1984
-
-
Rowan, A.D.1
Hui, W.2
Cawston, T.E.3
Richards, C.D.4
-
12
-
-
0033810126
-
Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo
-
Langdon C., Kerr C., Hassen M., Hara T., Arsenault A.L., Richards C.D. Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo. Am J Pathol 2000, 157(4):1187-1196.
-
(2000)
Am J Pathol
, vol.157
, Issue.4
, pp. 1187-1196
-
-
Langdon, C.1
Kerr, C.2
Hassen, M.3
Hara, T.4
Arsenault, A.L.5
Richards, C.D.6
-
13
-
-
0346658321
-
Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo
-
Hui W., Rowan A.D., Richards C.D., Cawston T.E. Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo. Arthritis Rheum 2003, 48(12):3404-3418.
-
(2003)
Arthritis Rheum
, vol.48
, Issue.12
, pp. 3404-3418
-
-
Hui, W.1
Rowan, A.D.2
Richards, C.D.3
Cawston, T.E.4
-
14
-
-
32444448610
-
A model of inflammatory arthritis highlights a role for oncostatin M in pro-inflammatory cytokine-induced bone destruction via RANK/RANKL
-
Hui W., Cawston T.E., Richards C.D., Rowan A.D. A model of inflammatory arthritis highlights a role for oncostatin M in pro-inflammatory cytokine-induced bone destruction via RANK/RANKL. Arthritis Res Ther 2005, 7(1):R57-R64.
-
(2005)
Arthritis Res Ther
, vol.7
, Issue.1
-
-
Hui, W.1
Cawston, T.E.2
Richards, C.D.3
Rowan, A.D.4
-
15
-
-
33750289939
-
Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures
-
Fearon U., Mullan R., Markham T., Connolly M., Sullivan S., Poole A.R., et al. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures. Arthritis Rheum 2006, 54(10):3152-3162.
-
(2006)
Arthritis Rheum
, vol.54
, Issue.10
, pp. 3152-3162
-
-
Fearon, U.1
Mullan, R.2
Markham, T.3
Connolly, M.4
Sullivan, S.5
Poole, A.R.6
-
16
-
-
0024592982
-
Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis
-
Guerne P.A., Zuraw B.L., Vaughan J.H., Carson D.A., Lotz M. Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. J Clin Invest 1989, 83(2):585-592.
-
(1989)
J Clin Invest
, vol.83
, Issue.2
, pp. 585-592
-
-
Guerne, P.A.1
Zuraw, B.L.2
Vaughan, J.H.3
Carson, D.A.4
Lotz, M.5
-
17
-
-
0028288138
-
Interaction between oncostatin M, interleukin 1 and prostaglandin E2 in induction of IL-6 expression in human fibroblasts
-
Richards C.D., Agro A. Interaction between oncostatin M, interleukin 1 and prostaglandin E2 in induction of IL-6 expression in human fibroblasts. Cytokine 1994, 6(1):40-47.
-
(1994)
Cytokine
, vol.6
, Issue.1
, pp. 40-47
-
-
Richards, C.D.1
Agro, A.2
-
18
-
-
0033516661
-
STAT3 activation in stromal/osteoblastic cells is required for induction of the receptor activator of NF-kappaB ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D3 or parathyroid hormone
-
O'Brien C.A., Gubrij I., Lin S.C., Saylors R.L., Manolagas S.C. STAT3 activation in stromal/osteoblastic cells is required for induction of the receptor activator of NF-kappaB ligand and stimulation of osteoclastogenesis by gp130-utilizing cytokines or interleukin-1 but not 1,25-dihydroxyvitamin D3 or parathyroid hormone. J Biol Chem 1999, 274(27):19301-19308.
-
(1999)
J Biol Chem
, vol.274
, Issue.27
, pp. 19301-19308
-
-
O'Brien, C.A.1
Gubrij, I.2
Lin, S.C.3
Saylors, R.L.4
Manolagas, S.C.5
-
19
-
-
0037105542
-
IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae
-
Palmqvist P., Persson E., Conaway H.H., Lerner U.H. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae. J Immunol 2002, 169(6):3353-3362.
-
(2002)
J Immunol
, vol.169
, Issue.6
, pp. 3353-3362
-
-
Palmqvist, P.1
Persson, E.2
Conaway, H.H.3
Lerner, U.H.4
-
20
-
-
76649121173
-
Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice
-
Walker E.C., McGregor N.E., Poulton I.J., Solano M., Pompolo S., Fernandes T.J., et al. Oncostatin M promotes bone formation independently of resorption when signaling through leukemia inhibitory factor receptor in mice. J Clin Invest 2010, 120(2):582-592.
-
(2010)
J Clin Invest
, vol.120
, Issue.2
, pp. 582-592
-
-
Walker, E.C.1
McGregor, N.E.2
Poulton, I.J.3
Solano, M.4
Pompolo, S.5
Fernandes, T.J.6
-
21
-
-
0028301594
-
Oncostatin M binds directly to gp130 and behaves as interleukin-6 antagonist on a cell line expressing gp130 but lacking functional oncostatin M receptors
-
Sporeno E., Paonessa G., Salvati A.L., Graziani R., Delmastro P., Ciliberto G., et al. Oncostatin M binds directly to gp130 and behaves as interleukin-6 antagonist on a cell line expressing gp130 but lacking functional oncostatin M receptors. J Biol Chem 1994, 269(15):10991-10995.
-
(1994)
J Biol Chem
, vol.269
, Issue.15
, pp. 10991-10995
-
-
Sporeno, E.1
Paonessa, G.2
Salvati, A.L.3
Graziani, R.4
Delmastro, P.5
Ciliberto, G.6
-
22
-
-
12644294970
-
Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation
-
Mosley B., De Imus C., Friend D., Boiani N., Thoma B., Park L.S., et al. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem 1996, 271(51):32635-32643.
-
(1996)
J Biol Chem
, vol.271
, Issue.51
, pp. 32635-32643
-
-
Mosley, B.1
De Imus, C.2
Friend, D.3
Boiani, N.4
Thoma, B.5
Park, L.S.6
-
23
-
-
0031814308
-
Cloning and characterization of a specific receptor for mouse oncostatin M
-
Lindberg R.A., Juan T.S., Welcher A.A., Sun Y., Cupples R., Guthrie B., et al. Cloning and characterization of a specific receptor for mouse oncostatin M. Mol Cell Biol 1998, 18(6):3357-3367.
-
(1998)
Mol Cell Biol
, vol.18
, Issue.6
, pp. 3357-3367
-
-
Lindberg, R.A.1
Juan, T.S.2
Welcher, A.A.3
Sun, Y.4
Cupples, R.5
Guthrie, B.6
-
24
-
-
0031010058
-
Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice
-
Ichihara M., Hara T., Kim H., Murate T., Miyajima A. Oncostatin M and leukemia inhibitory factor do not use the same functional receptor in mice. Blood 1997, 90(1):165-173.
-
(1997)
Blood
, vol.90
, Issue.1
, pp. 165-173
-
-
Ichihara, M.1
Hara, T.2
Kim, H.3
Murate, T.4
Miyajima, A.5
-
25
-
-
0142214644
-
Targeted disruption of oncostatin M receptor results in altered hematopoiesis
-
Tanaka M., Hirabayashi Y., Sekiguchi T., Inoue T., Katsuki M., Miyajima A. Targeted disruption of oncostatin M receptor results in altered hematopoiesis. Blood 2003, 102(9):3154-3162.
-
(2003)
Blood
, vol.102
, Issue.9
, pp. 3154-3162
-
-
Tanaka, M.1
Hirabayashi, Y.2
Sekiguchi, T.3
Inoue, T.4
Katsuki, M.5
Miyajima, A.6
-
26
-
-
31044449633
-
Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis
-
Wong P.K., Quinn J.M., Sims N.A., van Nieuwenhuijze A., Campbell I.K., Wicks I.P. Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis. Arthritis Rheum 2006, 54(1):158-168.
-
(2006)
Arthritis Rheum
, vol.54
, Issue.1
, pp. 158-168
-
-
Wong, P.K.1
Quinn, J.M.2
Sims, N.A.3
van Nieuwenhuijze, A.4
Campbell, I.K.5
Wicks, I.P.6
-
27
-
-
61649090825
-
GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis
-
van Hamburg J.P., Mus A.M., de Bruijn M.J., de Vogel L., Boon L., Cornelissen F., et al. GATA-3 protects against severe joint inflammation and bone erosion and reduces differentiation of Th17 cells during experimental arthritis. Arthritis Rheum 2009, 60(3):750-759.
-
(2009)
Arthritis Rheum
, vol.60
, Issue.3
, pp. 750-759
-
-
van Hamburg, J.P.1
Mus, A.M.2
de Bruijn, M.J.3
de Vogel, L.4
Boon, L.5
Cornelissen, F.6
-
28
-
-
33749604848
-
RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis
-
Pettit A.R., Walsh N.C., Manning C., Goldring S.R., Gravallese E.M. RANKL protein is expressed at the pannus-bone interface at sites of articular bone erosion in rheumatoid arthritis. Rheumatology (Oxford) 2006, 45(9):1068-1076.
-
(2006)
Rheumatology (Oxford)
, vol.45
, Issue.9
, pp. 1068-1076
-
-
Pettit, A.R.1
Walsh, N.C.2
Manning, C.3
Goldring, S.R.4
Gravallese, E.M.5
-
29
-
-
33847133943
-
Cadherin-11 in synovial lining formation and pathology in arthritis
-
Lee D.M., Kiener H.P., Agarwal S.K., Noss E.H., Watts G.F., Chisaka O., et al. Cadherin-11 in synovial lining formation and pathology in arthritis. Science 2007, 315(5814):1006-1010.
-
(2007)
Science
, vol.315
, Issue.5814
, pp. 1006-1010
-
-
Lee, D.M.1
Kiener, H.P.2
Agarwal, S.K.3
Noss, E.H.4
Watts, G.F.5
Chisaka, O.6
-
30
-
-
0035710746
-
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method
-
Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25(4):402-408.
-
(2001)
Methods
, vol.25
, Issue.4
, pp. 402-408
-
-
Livak, K.J.1
Schmittgen, T.D.2
-
31
-
-
0035861559
-
Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor alpha, and oncostatin M receptor beta by distinct mechanisms
-
Blanchard F., Wang Y., Kinzie E., Duplomb L., Godard A., Baumann H. Oncostatin M regulates the synthesis and turnover of gp130, leukemia inhibitory factor receptor alpha, and oncostatin M receptor beta by distinct mechanisms. J Biol Chem 2001, 276(50):47038-47045.
-
(2001)
J Biol Chem
, vol.276
, Issue.50
, pp. 47038-47045
-
-
Blanchard, F.1
Wang, Y.2
Kinzie, E.3
Duplomb, L.4
Godard, A.5
Baumann, H.6
-
32
-
-
70349319715
-
Targeting IL-6 in the treatment of inflammatory and autoimmune diseases
-
Ding C., Cicuttini F., Li J., Jones G. Targeting IL-6 in the treatment of inflammatory and autoimmune diseases. Expert Opin Investig Drugs 2009, 18(10):1457-1466.
-
(2009)
Expert Opin Investig Drugs
, vol.18
, Issue.10
, pp. 1457-1466
-
-
Ding, C.1
Cicuttini, F.2
Li, J.3
Jones, G.4
-
33
-
-
77956529798
-
GP130 cytokines and bone remodelling in health and disease
-
Sims N.A., Walsh N.C. GP130 cytokines and bone remodelling in health and disease. BMB Rep 2010, 43(8):513-523.
-
(2010)
BMB Rep
, vol.43
, Issue.8
, pp. 513-523
-
-
Sims, N.A.1
Walsh, N.C.2
-
34
-
-
0034121039
-
Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis
-
Takayanagi H., Iizuka H., Juji T., Nakagawa T., Yamamoto A., Miyazaki T., et al. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum 2000, 43(2):259-269.
-
(2000)
Arthritis Rheum
, vol.43
, Issue.2
, pp. 259-269
-
-
Takayanagi, H.1
Iizuka, H.2
Juji, T.3
Nakagawa, T.4
Yamamoto, A.5
Miyazaki, T.6
-
35
-
-
0034122050
-
Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor
-
Gravallese E.M., Manning C., Tsay A., Naito A., Pan C., Amento E., et al. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 2000, 43(2):250-258.
-
(2000)
Arthritis Rheum
, vol.43
, Issue.2
, pp. 250-258
-
-
Gravallese, E.M.1
Manning, C.2
Tsay, A.3
Naito, A.4
Pan, C.5
Amento, E.6
-
36
-
-
40549088214
-
The abundant synovial expression of the RANK/RANKL/osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation
-
Vandooren B., Cantaert T., Noordenbos T., Tak P.P., Baeten D. The abundant synovial expression of the RANK/RANKL/osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation. Arthritis Rheum 2008, 58(3):718-729.
-
(2008)
Arthritis Rheum
, vol.58
, Issue.3
, pp. 718-729
-
-
Vandooren, B.1
Cantaert, T.2
Noordenbos, T.3
Tak, P.P.4
Baeten, D.5
-
37
-
-
0036092333
-
Adenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-kappa B ligand
-
de Hooge A.S., van de Loo F.A., Bennink M.B., de Jong D.S., Arntz O.J., Lubberts E., et al. Adenoviral transfer of murine oncostatin M elicits periosteal bone apposition in knee joints of mice, despite synovial inflammation and up-regulated expression of interleukin-6 and receptor activator of nuclear factor-kappa B ligand. Am J Pathol 2002, 160(5):1733-1743.
-
(2002)
Am J Pathol
, vol.160
, Issue.5
, pp. 1733-1743
-
-
de Hooge, A.S.1
van de Loo, F.A.2
Bennink, M.B.3
de Jong, D.S.4
Arntz, O.J.5
Lubberts, E.6
-
38
-
-
54449101331
-
IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17
-
Hashizume M., Hayakawa N., Mihara M. IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17. Rheumatology (Oxford) 2008, 47(11):1635-1640.
-
(2008)
Rheumatology (Oxford)
, vol.47
, Issue.11
, pp. 1635-1640
-
-
Hashizume, M.1
Hayakawa, N.2
Mihara, M.3
-
39
-
-
18844447702
-
Oncostatin M causes VEGF release from human airway smooth muscle: synergy with IL-1beta
-
L1040-8
-
Faffe D.S., Flynt L., Mellema M., Whitehead T.R., Bourgeois K., Panettieri R.A., et al. Oncostatin M causes VEGF release from human airway smooth muscle: synergy with IL-1beta. Am J Physiol Lung Cell Mol Physiol 2005, 288(6):L1040-8.
-
(2005)
Am J Physiol Lung Cell Mol Physiol
, vol.288
, Issue.6
-
-
Faffe, D.S.1
Flynt, L.2
Mellema, M.3
Whitehead, T.R.4
Bourgeois, K.5
Panettieri, R.A.6
-
40
-
-
77957113217
-
Oncostatin M synergistically induces CXCL10 and ICAM-1 expression in IL-1beta-stimulated-human gingival fibroblasts
-
Hosokawa Y., Hosokawa I., Ozaki K., Nakae H., Matsuo T. Oncostatin M synergistically induces CXCL10 and ICAM-1 expression in IL-1beta-stimulated-human gingival fibroblasts. J Cell Biochem 2010, 111(1):40-48.
-
(2010)
J Cell Biochem
, vol.111
, Issue.1
, pp. 40-48
-
-
Hosokawa, Y.1
Hosokawa, I.2
Ozaki, K.3
Nakae, H.4
Matsuo, T.5
-
41
-
-
0033987112
-
The role of p38 mitogen-activated protein kinase in IL-6 and IL-8 production from the TNF-alpha- or IL-1beta-stimulated rheumatoid synovial fibroblasts
-
Suzuki M., Tetsuka T., Yoshida S., Watanabe N., Kobayashi M., Matsui N., et al. The role of p38 mitogen-activated protein kinase in IL-6 and IL-8 production from the TNF-alpha- or IL-1beta-stimulated rheumatoid synovial fibroblasts. FEBS Lett 2000, 465(1):23-27.
-
(2000)
FEBS Lett
, vol.465
, Issue.1
, pp. 23-27
-
-
Suzuki, M.1
Tetsuka, T.2
Yoshida, S.3
Watanabe, N.4
Kobayashi, M.5
Matsui, N.6
-
42
-
-
73249152293
-
A novel distal enhancer mediates cytokine induction of mouse RANKl gene expression
-
Bishop K.A., Meyer M.B., Pike J.W. A novel distal enhancer mediates cytokine induction of mouse RANKl gene expression. Mol Endocrinol 2009, 23(12):2095-2110.
-
(2009)
Mol Endocrinol
, vol.23
, Issue.12
, pp. 2095-2110
-
-
Bishop, K.A.1
Meyer, M.B.2
Pike, J.W.3
-
43
-
-
84856018781
-
Phase 2B dose-ranging study of the oral JAK inhibitor to facitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to DMARDs
-
Fleischmann R., Cutolo M., Genovese M.C., Lee E.B., Kanik K.S., Sadis S., et al. Phase 2B dose-ranging study of the oral JAK inhibitor to facitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to DMARDs. Arthritis Rheum 2011.
-
(2011)
Arthritis Rheum
-
-
Fleischmann, R.1
Cutolo, M.2
Genovese, M.C.3
Lee, E.B.4
Kanik, K.S.5
Sadis, S.6
-
44
-
-
79955673696
-
CP690,550 inhibits oncostatin M-induced JAK/STAT signaling pathway in rheumatoid synoviocytes
-
Migita K., Komori A., Torigoshi T., Maeda Y., Izumi Y., Jiuchi Y., et al. CP690,550 inhibits oncostatin M-induced JAK/STAT signaling pathway in rheumatoid synoviocytes. Arthritis Res Ther 2011, 13(3):R72.
-
(2011)
Arthritis Res Ther
, vol.13
, Issue.3
-
-
Migita, K.1
Komori, A.2
Torigoshi, T.3
Maeda, Y.4
Izumi, Y.5
Jiuchi, Y.6
|